A UK multicentre audit of the management of patients with primary hypercholesterolaemia or mixed dyslipidaemia with bempedoic acid against published lipid-lowering treatment targets

Background: Bempedoic acid, an adenosine triphosphate citrate lyase inhibitor, was introduced to UK practice via a pre-reimbursement access scheme for adults with primary hypercholesterolaemia or mixed dyslipidaemia who are at high risk of cardiovascular disease, in whom statins are either not toler...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Sudarshan Ramachandran, Amro Maarouf, Karen Mitchell, Tony Avades, Peter Smith, Lee Boulton, Jennifer Kelly, Nitasha Vekaria, Elizabeth Hughes
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	BioExcel Publishing Ltd 2024-08-01
Ráidu:	Drugs in Context
Fáttát:	adenosine triphosphate bempedoic acid cholesterol hydroxymethylglutaryl coa reductases hypercholesterolaemia lipoprotein
Liŋkkat:	https://www.drugsincontext.com/a-uk-multicentre-audit-of-the-management-of-patients-with-primary-hypercholesterolaemia-or-mixed-dyslipidaemia-with-bempedoic-acid-against-published-lipid-lowering-treatment-targets/
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!